Global Hormone Disorder Drug Supply, Demand and Key Producers, 2023-2029
The global Hormone Disorder Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Hormone Disorder Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hormone Disorder Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hormone Disorder Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hormone Disorder Drug total production and demand, 2018-2029, (K Units)
Global Hormone Disorder Drug total production value, 2018-2029, (USD Million)
Global Hormone Disorder Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hormone Disorder Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hormone Disorder Drug domestic production, consumption, key domestic manufacturers and share
Global Hormone Disorder Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hormone Disorder Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hormone Disorder Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hormone Disorder Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hormone Disorder Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hormone Disorder Drug Market, By Region:
1. How big is the global Hormone Disorder Drug market?
2. What is the demand of the global Hormone Disorder Drug market?
3. What is the year over year growth of the global Hormone Disorder Drug market?
4. What is the production and production value of the global Hormone Disorder Drug market?
5. Who are the key producers in the global Hormone Disorder Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Hormone Disorder Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hormone Disorder Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hormone Disorder Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hormone Disorder Drug total production and demand, 2018-2029, (K Units)
Global Hormone Disorder Drug total production value, 2018-2029, (USD Million)
Global Hormone Disorder Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hormone Disorder Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hormone Disorder Drug domestic production, consumption, key domestic manufacturers and share
Global Hormone Disorder Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hormone Disorder Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hormone Disorder Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hormone Disorder Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hormone Disorder Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hormone Disorder Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Growth Hormone Stimulator
- Growth Hormone Inhibitor
- Dwarfism
- Gigantism
- Other
- Teva Pharmaceutical Industries Ltd
- Amneal Pharmaceutical Inc
- Mayne Pharma Group Limited
- Merck KGaA
- Sanofi
- Sun Pharmaceutical Industries Ltd
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Abbott
- PT. Daewoong Pharmaceutical Company
- Genentech, Inc
- Bausch Health Companies Inc
- Lilly
- Ipsen Pharma
- Ferring B.V
1. How big is the global Hormone Disorder Drug market?
2. What is the demand of the global Hormone Disorder Drug market?
3. What is the year over year growth of the global Hormone Disorder Drug market?
4. What is the production and production value of the global Hormone Disorder Drug market?
5. Who are the key producers in the global Hormone Disorder Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hormone Disorder Drug Introduction
1.2 World Hormone Disorder Drug Supply & Forecast
1.2.1 World Hormone Disorder Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Hormone Disorder Drug Production (2018-2029)
1.2.3 World Hormone Disorder Drug Pricing Trends (2018-2029)
1.3 World Hormone Disorder Drug Production by Region (Based on Production Site)
1.3.1 World Hormone Disorder Drug Production Value by Region (2018-2029)
1.3.2 World Hormone Disorder Drug Production by Region (2018-2029)
1.3.3 World Hormone Disorder Drug Average Price by Region (2018-2029)
1.3.4 North America Hormone Disorder Drug Production (2018-2029)
1.3.5 Europe Hormone Disorder Drug Production (2018-2029)
1.3.6 China Hormone Disorder Drug Production (2018-2029)
1.3.7 Japan Hormone Disorder Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hormone Disorder Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hormone Disorder Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hormone Disorder Drug Demand (2018-2029)
2.2 World Hormone Disorder Drug Consumption by Region
2.2.1 World Hormone Disorder Drug Consumption by Region (2018-2023)
2.2.2 World Hormone Disorder Drug Consumption Forecast by Region (2024-2029)
2.3 United States Hormone Disorder Drug Consumption (2018-2029)
2.4 China Hormone Disorder Drug Consumption (2018-2029)
2.5 Europe Hormone Disorder Drug Consumption (2018-2029)
2.6 Japan Hormone Disorder Drug Consumption (2018-2029)
2.7 South Korea Hormone Disorder Drug Consumption (2018-2029)
2.8 ASEAN Hormone Disorder Drug Consumption (2018-2029)
2.9 India Hormone Disorder Drug Consumption (2018-2029)
3 WORLD HORMONE DISORDER DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hormone Disorder Drug Production Value by Manufacturer (2018-2023)
3.2 World Hormone Disorder Drug Production by Manufacturer (2018-2023)
3.3 World Hormone Disorder Drug Average Price by Manufacturer (2018-2023)
3.4 Hormone Disorder Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hormone Disorder Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hormone Disorder Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Hormone Disorder Drug in 2022
3.6 Hormone Disorder Drug Market: Overall Company Footprint Analysis
3.6.1 Hormone Disorder Drug Market: Region Footprint
3.6.2 Hormone Disorder Drug Market: Company Product Type Footprint
3.6.3 Hormone Disorder Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hormone Disorder Drug Production Value Comparison
4.1.1 United States VS China: Hormone Disorder Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hormone Disorder Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hormone Disorder Drug Production Comparison
4.2.1 United States VS China: Hormone Disorder Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hormone Disorder Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hormone Disorder Drug Consumption Comparison
4.3.1 United States VS China: Hormone Disorder Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hormone Disorder Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hormone Disorder Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hormone Disorder Drug Production (2018-2023)
4.5 China Based Hormone Disorder Drug Manufacturers and Market Share
4.5.1 China Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Hormone Disorder Drug Production (2018-2023)
4.6 Rest of World Based Hormone Disorder Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hormone Disorder Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hormone Disorder Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Growth Hormone Stimulator
5.2.2 Growth Hormone Inhibitor
5.3 Market Segment by Type
5.3.1 World Hormone Disorder Drug Production by Type (2018-2029)
5.3.2 World Hormone Disorder Drug Production Value by Type (2018-2029)
5.3.3 World Hormone Disorder Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hormone Disorder Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Dwarfism
6.2.2 Gigantism
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hormone Disorder Drug Production by Application (2018-2029)
6.3.2 World Hormone Disorder Drug Production Value by Application (2018-2029)
6.3.3 World Hormone Disorder Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Details
7.1.2 Teva Pharmaceutical Industries Ltd Major Business
7.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
7.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.1.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.2 Amneal Pharmaceutical Inc
7.2.1 Amneal Pharmaceutical Inc Details
7.2.2 Amneal Pharmaceutical Inc Major Business
7.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Product and Services
7.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Pharmaceutical Inc Recent Developments/Updates
7.2.6 Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
7.3 Mayne Pharma Group Limited
7.3.1 Mayne Pharma Group Limited Details
7.3.2 Mayne Pharma Group Limited Major Business
7.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Product and Services
7.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mayne Pharma Group Limited Recent Developments/Updates
7.3.6 Mayne Pharma Group Limited Competitive Strengths & Weaknesses
7.4 Merck KGaA
7.4.1 Merck KGaA Details
7.4.2 Merck KGaA Major Business
7.4.3 Merck KGaA Hormone Disorder Drug Product and Services
7.4.4 Merck KGaA Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck KGaA Recent Developments/Updates
7.4.6 Merck KGaA Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Hormone Disorder Drug Product and Services
7.5.4 Sanofi Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Sun Pharmaceutical Industries Ltd
7.6.1 Sun Pharmaceutical Industries Ltd Details
7.6.2 Sun Pharmaceutical Industries Ltd Major Business
7.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
7.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Hormone Disorder Drug Product and Services
7.7.4 Novartis AG Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Details
7.8.2 F. Hoffmann-La Roche Ltd Major Business
7.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product and Services
7.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.8.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.9 Abbott
7.9.1 Abbott Details
7.9.2 Abbott Major Business
7.9.3 Abbott Hormone Disorder Drug Product and Services
7.9.4 Abbott Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Abbott Recent Developments/Updates
7.9.6 Abbott Competitive Strengths & Weaknesses
7.10 PT. Daewoong Pharmaceutical Company
7.10.1 PT. Daewoong Pharmaceutical Company Details
7.10.2 PT. Daewoong Pharmaceutical Company Major Business
7.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product and Services
7.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 PT. Daewoong Pharmaceutical Company Recent Developments/Updates
7.10.6 PT. Daewoong Pharmaceutical Company Competitive Strengths & Weaknesses
7.11 Genentech, Inc
7.11.1 Genentech, Inc Details
7.11.2 Genentech, Inc Major Business
7.11.3 Genentech, Inc Hormone Disorder Drug Product and Services
7.11.4 Genentech, Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Genentech, Inc Recent Developments/Updates
7.11.6 Genentech, Inc Competitive Strengths & Weaknesses
7.12 Bausch Health Companies Inc
7.12.1 Bausch Health Companies Inc Details
7.12.2 Bausch Health Companies Inc Major Business
7.12.3 Bausch Health Companies Inc Hormone Disorder Drug Product and Services
7.12.4 Bausch Health Companies Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bausch Health Companies Inc Recent Developments/Updates
7.12.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.13 Lilly
7.13.1 Lilly Details
7.13.2 Lilly Major Business
7.13.3 Lilly Hormone Disorder Drug Product and Services
7.13.4 Lilly Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Lilly Recent Developments/Updates
7.13.6 Lilly Competitive Strengths & Weaknesses
7.14 Ipsen Pharma
7.14.1 Ipsen Pharma Details
7.14.2 Ipsen Pharma Major Business
7.14.3 Ipsen Pharma Hormone Disorder Drug Product and Services
7.14.4 Ipsen Pharma Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ipsen Pharma Recent Developments/Updates
7.14.6 Ipsen Pharma Competitive Strengths & Weaknesses
7.15 Ferring B.V
7.15.1 Ferring B.V Details
7.15.2 Ferring B.V Major Business
7.15.3 Ferring B.V Hormone Disorder Drug Product and Services
7.15.4 Ferring B.V Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Ferring B.V Recent Developments/Updates
7.15.6 Ferring B.V Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hormone Disorder Drug Industry Chain
8.2 Hormone Disorder Drug Upstream Analysis
8.2.1 Hormone Disorder Drug Core Raw Materials
8.2.2 Main Manufacturers of Hormone Disorder Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hormone Disorder Drug Production Mode
8.6 Hormone Disorder Drug Procurement Model
8.7 Hormone Disorder Drug Industry Sales Model and Sales Channels
8.7.1 Hormone Disorder Drug Sales Model
8.7.2 Hormone Disorder Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hormone Disorder Drug Introduction
1.2 World Hormone Disorder Drug Supply & Forecast
1.2.1 World Hormone Disorder Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Hormone Disorder Drug Production (2018-2029)
1.2.3 World Hormone Disorder Drug Pricing Trends (2018-2029)
1.3 World Hormone Disorder Drug Production by Region (Based on Production Site)
1.3.1 World Hormone Disorder Drug Production Value by Region (2018-2029)
1.3.2 World Hormone Disorder Drug Production by Region (2018-2029)
1.3.3 World Hormone Disorder Drug Average Price by Region (2018-2029)
1.3.4 North America Hormone Disorder Drug Production (2018-2029)
1.3.5 Europe Hormone Disorder Drug Production (2018-2029)
1.3.6 China Hormone Disorder Drug Production (2018-2029)
1.3.7 Japan Hormone Disorder Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hormone Disorder Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hormone Disorder Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hormone Disorder Drug Demand (2018-2029)
2.2 World Hormone Disorder Drug Consumption by Region
2.2.1 World Hormone Disorder Drug Consumption by Region (2018-2023)
2.2.2 World Hormone Disorder Drug Consumption Forecast by Region (2024-2029)
2.3 United States Hormone Disorder Drug Consumption (2018-2029)
2.4 China Hormone Disorder Drug Consumption (2018-2029)
2.5 Europe Hormone Disorder Drug Consumption (2018-2029)
2.6 Japan Hormone Disorder Drug Consumption (2018-2029)
2.7 South Korea Hormone Disorder Drug Consumption (2018-2029)
2.8 ASEAN Hormone Disorder Drug Consumption (2018-2029)
2.9 India Hormone Disorder Drug Consumption (2018-2029)
3 WORLD HORMONE DISORDER DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hormone Disorder Drug Production Value by Manufacturer (2018-2023)
3.2 World Hormone Disorder Drug Production by Manufacturer (2018-2023)
3.3 World Hormone Disorder Drug Average Price by Manufacturer (2018-2023)
3.4 Hormone Disorder Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hormone Disorder Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hormone Disorder Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Hormone Disorder Drug in 2022
3.6 Hormone Disorder Drug Market: Overall Company Footprint Analysis
3.6.1 Hormone Disorder Drug Market: Region Footprint
3.6.2 Hormone Disorder Drug Market: Company Product Type Footprint
3.6.3 Hormone Disorder Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hormone Disorder Drug Production Value Comparison
4.1.1 United States VS China: Hormone Disorder Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hormone Disorder Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hormone Disorder Drug Production Comparison
4.2.1 United States VS China: Hormone Disorder Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hormone Disorder Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hormone Disorder Drug Consumption Comparison
4.3.1 United States VS China: Hormone Disorder Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hormone Disorder Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hormone Disorder Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hormone Disorder Drug Production (2018-2023)
4.5 China Based Hormone Disorder Drug Manufacturers and Market Share
4.5.1 China Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Hormone Disorder Drug Production (2018-2023)
4.6 Rest of World Based Hormone Disorder Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hormone Disorder Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hormone Disorder Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hormone Disorder Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Growth Hormone Stimulator
5.2.2 Growth Hormone Inhibitor
5.3 Market Segment by Type
5.3.1 World Hormone Disorder Drug Production by Type (2018-2029)
5.3.2 World Hormone Disorder Drug Production Value by Type (2018-2029)
5.3.3 World Hormone Disorder Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hormone Disorder Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Dwarfism
6.2.2 Gigantism
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hormone Disorder Drug Production by Application (2018-2029)
6.3.2 World Hormone Disorder Drug Production Value by Application (2018-2029)
6.3.3 World Hormone Disorder Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Details
7.1.2 Teva Pharmaceutical Industries Ltd Major Business
7.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
7.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.1.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.2 Amneal Pharmaceutical Inc
7.2.1 Amneal Pharmaceutical Inc Details
7.2.2 Amneal Pharmaceutical Inc Major Business
7.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Product and Services
7.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Pharmaceutical Inc Recent Developments/Updates
7.2.6 Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
7.3 Mayne Pharma Group Limited
7.3.1 Mayne Pharma Group Limited Details
7.3.2 Mayne Pharma Group Limited Major Business
7.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Product and Services
7.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mayne Pharma Group Limited Recent Developments/Updates
7.3.6 Mayne Pharma Group Limited Competitive Strengths & Weaknesses
7.4 Merck KGaA
7.4.1 Merck KGaA Details
7.4.2 Merck KGaA Major Business
7.4.3 Merck KGaA Hormone Disorder Drug Product and Services
7.4.4 Merck KGaA Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck KGaA Recent Developments/Updates
7.4.6 Merck KGaA Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Hormone Disorder Drug Product and Services
7.5.4 Sanofi Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Sun Pharmaceutical Industries Ltd
7.6.1 Sun Pharmaceutical Industries Ltd Details
7.6.2 Sun Pharmaceutical Industries Ltd Major Business
7.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
7.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Hormone Disorder Drug Product and Services
7.7.4 Novartis AG Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Details
7.8.2 F. Hoffmann-La Roche Ltd Major Business
7.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product and Services
7.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.8.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.9 Abbott
7.9.1 Abbott Details
7.9.2 Abbott Major Business
7.9.3 Abbott Hormone Disorder Drug Product and Services
7.9.4 Abbott Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Abbott Recent Developments/Updates
7.9.6 Abbott Competitive Strengths & Weaknesses
7.10 PT. Daewoong Pharmaceutical Company
7.10.1 PT. Daewoong Pharmaceutical Company Details
7.10.2 PT. Daewoong Pharmaceutical Company Major Business
7.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product and Services
7.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 PT. Daewoong Pharmaceutical Company Recent Developments/Updates
7.10.6 PT. Daewoong Pharmaceutical Company Competitive Strengths & Weaknesses
7.11 Genentech, Inc
7.11.1 Genentech, Inc Details
7.11.2 Genentech, Inc Major Business
7.11.3 Genentech, Inc Hormone Disorder Drug Product and Services
7.11.4 Genentech, Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Genentech, Inc Recent Developments/Updates
7.11.6 Genentech, Inc Competitive Strengths & Weaknesses
7.12 Bausch Health Companies Inc
7.12.1 Bausch Health Companies Inc Details
7.12.2 Bausch Health Companies Inc Major Business
7.12.3 Bausch Health Companies Inc Hormone Disorder Drug Product and Services
7.12.4 Bausch Health Companies Inc Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bausch Health Companies Inc Recent Developments/Updates
7.12.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.13 Lilly
7.13.1 Lilly Details
7.13.2 Lilly Major Business
7.13.3 Lilly Hormone Disorder Drug Product and Services
7.13.4 Lilly Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Lilly Recent Developments/Updates
7.13.6 Lilly Competitive Strengths & Weaknesses
7.14 Ipsen Pharma
7.14.1 Ipsen Pharma Details
7.14.2 Ipsen Pharma Major Business
7.14.3 Ipsen Pharma Hormone Disorder Drug Product and Services
7.14.4 Ipsen Pharma Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ipsen Pharma Recent Developments/Updates
7.14.6 Ipsen Pharma Competitive Strengths & Weaknesses
7.15 Ferring B.V
7.15.1 Ferring B.V Details
7.15.2 Ferring B.V Major Business
7.15.3 Ferring B.V Hormone Disorder Drug Product and Services
7.15.4 Ferring B.V Hormone Disorder Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Ferring B.V Recent Developments/Updates
7.15.6 Ferring B.V Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hormone Disorder Drug Industry Chain
8.2 Hormone Disorder Drug Upstream Analysis
8.2.1 Hormone Disorder Drug Core Raw Materials
8.2.2 Main Manufacturers of Hormone Disorder Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hormone Disorder Drug Production Mode
8.6 Hormone Disorder Drug Procurement Model
8.7 Hormone Disorder Drug Industry Sales Model and Sales Channels
8.7.1 Hormone Disorder Drug Sales Model
8.7.2 Hormone Disorder Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hormone Disorder Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hormone Disorder Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hormone Disorder Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hormone Disorder Drug Production Value Market Share by Region (2018-2023)
Table 5. World Hormone Disorder Drug Production Value Market Share by Region (2024-2029)
Table 6. World Hormone Disorder Drug Production by Region (2018-2023) & (K Units)
Table 7. World Hormone Disorder Drug Production by Region (2024-2029) & (K Units)
Table 8. World Hormone Disorder Drug Production Market Share by Region (2018-2023)
Table 9. World Hormone Disorder Drug Production Market Share by Region (2024-2029)
Table 10. World Hormone Disorder Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hormone Disorder Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hormone Disorder Drug Major Market Trends
Table 13. World Hormone Disorder Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hormone Disorder Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Hormone Disorder Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hormone Disorder Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hormone Disorder Drug Producers in 2022
Table 18. World Hormone Disorder Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hormone Disorder Drug Producers in 2022
Table 20. World Hormone Disorder Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hormone Disorder Drug Company Evaluation Quadrant
Table 22. World Hormone Disorder Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hormone Disorder Drug Production Site of Key Manufacturer
Table 24. Hormone Disorder Drug Market: Company Product Type Footprint
Table 25. Hormone Disorder Drug Market: Company Product Application Footprint
Table 26. Hormone Disorder Drug Competitive Factors
Table 27. Hormone Disorder Drug New Entrant and Capacity Expansion Plans
Table 28. Hormone Disorder Drug Mergers & Acquisitions Activity
Table 29. United States VS China Hormone Disorder Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hormone Disorder Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hormone Disorder Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 37. China Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 47. World Hormone Disorder Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Hormone Disorder Drug Production by Type (2018-2023) & (K Units)
Table 49. World Hormone Disorder Drug Production by Type (2024-2029) & (K Units)
Table 50. World Hormone Disorder Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Hormone Disorder Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Hormone Disorder Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Hormone Disorder Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Hormone Disorder Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hormone Disorder Drug Production by Application (2018-2023) & (K Units)
Table 56. World Hormone Disorder Drug Production by Application (2024-2029) & (K Units)
Table 57. World Hormone Disorder Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hormone Disorder Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hormone Disorder Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hormone Disorder Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Industries Ltd Major Business
Table 63. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
Table 64. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 66. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 67. Amneal Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Pharmaceutical Inc Major Business
Table 69. Amneal Pharmaceutical Inc Hormone Disorder Drug Product and Services
Table 70. Amneal Pharmaceutical Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Pharmaceutical Inc Recent Developments/Updates
Table 72. Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 73. Mayne Pharma Group Limited Basic Information, Manufacturing Base and Competitors
Table 74. Mayne Pharma Group Limited Major Business
Table 75. Mayne Pharma Group Limited Hormone Disorder Drug Product and Services
Table 76. Mayne Pharma Group Limited Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mayne Pharma Group Limited Recent Developments/Updates
Table 78. Mayne Pharma Group Limited Competitive Strengths & Weaknesses
Table 79. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 80. Merck KGaA Major Business
Table 81. Merck KGaA Hormone Disorder Drug Product and Services
Table 82. Merck KGaA Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck KGaA Recent Developments/Updates
Table 84. Merck KGaA Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Hormone Disorder Drug Product and Services
Table 88. Sanofi Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceutical Industries Ltd Major Business
Table 93. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
Table 94. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Hormone Disorder Drug Product and Services
Table 100. Novartis AG Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 104. F. Hoffmann-La Roche Ltd Major Business
Table 105. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product and Services
Table 106. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 108. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 109. Abbott Basic Information, Manufacturing Base and Competitors
Table 110. Abbott Major Business
Table 111. Abbott Hormone Disorder Drug Product and Services
Table 112. Abbott Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Abbott Recent Developments/Updates
Table 114. Abbott Competitive Strengths & Weaknesses
Table 115. PT. Daewoong Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 116. PT. Daewoong Pharmaceutical Company Major Business
Table 117. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product and Services
Table 118. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. PT. Daewoong Pharmaceutical Company Recent Developments/Updates
Table 120. PT. Daewoong Pharmaceutical Company Competitive Strengths & Weaknesses
Table 121. Genentech, Inc Basic Information, Manufacturing Base and Competitors
Table 122. Genentech, Inc Major Business
Table 123. Genentech, Inc Hormone Disorder Drug Product and Services
Table 124. Genentech, Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Genentech, Inc Recent Developments/Updates
Table 126. Genentech, Inc Competitive Strengths & Weaknesses
Table 127. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 128. Bausch Health Companies Inc Major Business
Table 129. Bausch Health Companies Inc Hormone Disorder Drug Product and Services
Table 130. Bausch Health Companies Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bausch Health Companies Inc Recent Developments/Updates
Table 132. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 133. Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Lilly Major Business
Table 135. Lilly Hormone Disorder Drug Product and Services
Table 136. Lilly Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Lilly Recent Developments/Updates
Table 138. Lilly Competitive Strengths & Weaknesses
Table 139. Ipsen Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Ipsen Pharma Major Business
Table 141. Ipsen Pharma Hormone Disorder Drug Product and Services
Table 142. Ipsen Pharma Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ipsen Pharma Recent Developments/Updates
Table 144. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 145. Ferring B.V Major Business
Table 146. Ferring B.V Hormone Disorder Drug Product and Services
Table 147. Ferring B.V Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Hormone Disorder Drug Upstream (Raw Materials)
Table 149. Hormone Disorder Drug Typical Customers
Table 150. Hormone Disorder Drug Typical Distributors
Table 1. World Hormone Disorder Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hormone Disorder Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hormone Disorder Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hormone Disorder Drug Production Value Market Share by Region (2018-2023)
Table 5. World Hormone Disorder Drug Production Value Market Share by Region (2024-2029)
Table 6. World Hormone Disorder Drug Production by Region (2018-2023) & (K Units)
Table 7. World Hormone Disorder Drug Production by Region (2024-2029) & (K Units)
Table 8. World Hormone Disorder Drug Production Market Share by Region (2018-2023)
Table 9. World Hormone Disorder Drug Production Market Share by Region (2024-2029)
Table 10. World Hormone Disorder Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hormone Disorder Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hormone Disorder Drug Major Market Trends
Table 13. World Hormone Disorder Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hormone Disorder Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Hormone Disorder Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hormone Disorder Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hormone Disorder Drug Producers in 2022
Table 18. World Hormone Disorder Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hormone Disorder Drug Producers in 2022
Table 20. World Hormone Disorder Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hormone Disorder Drug Company Evaluation Quadrant
Table 22. World Hormone Disorder Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hormone Disorder Drug Production Site of Key Manufacturer
Table 24. Hormone Disorder Drug Market: Company Product Type Footprint
Table 25. Hormone Disorder Drug Market: Company Product Application Footprint
Table 26. Hormone Disorder Drug Competitive Factors
Table 27. Hormone Disorder Drug New Entrant and Capacity Expansion Plans
Table 28. Hormone Disorder Drug Mergers & Acquisitions Activity
Table 29. United States VS China Hormone Disorder Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hormone Disorder Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hormone Disorder Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 37. China Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Hormone Disorder Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hormone Disorder Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hormone Disorder Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hormone Disorder Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hormone Disorder Drug Production Market Share (2018-2023)
Table 47. World Hormone Disorder Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Hormone Disorder Drug Production by Type (2018-2023) & (K Units)
Table 49. World Hormone Disorder Drug Production by Type (2024-2029) & (K Units)
Table 50. World Hormone Disorder Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Hormone Disorder Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Hormone Disorder Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Hormone Disorder Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Hormone Disorder Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hormone Disorder Drug Production by Application (2018-2023) & (K Units)
Table 56. World Hormone Disorder Drug Production by Application (2024-2029) & (K Units)
Table 57. World Hormone Disorder Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hormone Disorder Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hormone Disorder Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hormone Disorder Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Industries Ltd Major Business
Table 63. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
Table 64. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 66. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 67. Amneal Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Pharmaceutical Inc Major Business
Table 69. Amneal Pharmaceutical Inc Hormone Disorder Drug Product and Services
Table 70. Amneal Pharmaceutical Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Pharmaceutical Inc Recent Developments/Updates
Table 72. Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 73. Mayne Pharma Group Limited Basic Information, Manufacturing Base and Competitors
Table 74. Mayne Pharma Group Limited Major Business
Table 75. Mayne Pharma Group Limited Hormone Disorder Drug Product and Services
Table 76. Mayne Pharma Group Limited Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mayne Pharma Group Limited Recent Developments/Updates
Table 78. Mayne Pharma Group Limited Competitive Strengths & Weaknesses
Table 79. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 80. Merck KGaA Major Business
Table 81. Merck KGaA Hormone Disorder Drug Product and Services
Table 82. Merck KGaA Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck KGaA Recent Developments/Updates
Table 84. Merck KGaA Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Hormone Disorder Drug Product and Services
Table 88. Sanofi Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceutical Industries Ltd Major Business
Table 93. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product and Services
Table 94. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Hormone Disorder Drug Product and Services
Table 100. Novartis AG Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 104. F. Hoffmann-La Roche Ltd Major Business
Table 105. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product and Services
Table 106. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 108. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 109. Abbott Basic Information, Manufacturing Base and Competitors
Table 110. Abbott Major Business
Table 111. Abbott Hormone Disorder Drug Product and Services
Table 112. Abbott Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Abbott Recent Developments/Updates
Table 114. Abbott Competitive Strengths & Weaknesses
Table 115. PT. Daewoong Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 116. PT. Daewoong Pharmaceutical Company Major Business
Table 117. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product and Services
Table 118. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. PT. Daewoong Pharmaceutical Company Recent Developments/Updates
Table 120. PT. Daewoong Pharmaceutical Company Competitive Strengths & Weaknesses
Table 121. Genentech, Inc Basic Information, Manufacturing Base and Competitors
Table 122. Genentech, Inc Major Business
Table 123. Genentech, Inc Hormone Disorder Drug Product and Services
Table 124. Genentech, Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Genentech, Inc Recent Developments/Updates
Table 126. Genentech, Inc Competitive Strengths & Weaknesses
Table 127. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 128. Bausch Health Companies Inc Major Business
Table 129. Bausch Health Companies Inc Hormone Disorder Drug Product and Services
Table 130. Bausch Health Companies Inc Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bausch Health Companies Inc Recent Developments/Updates
Table 132. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 133. Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Lilly Major Business
Table 135. Lilly Hormone Disorder Drug Product and Services
Table 136. Lilly Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Lilly Recent Developments/Updates
Table 138. Lilly Competitive Strengths & Weaknesses
Table 139. Ipsen Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Ipsen Pharma Major Business
Table 141. Ipsen Pharma Hormone Disorder Drug Product and Services
Table 142. Ipsen Pharma Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ipsen Pharma Recent Developments/Updates
Table 144. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 145. Ferring B.V Major Business
Table 146. Ferring B.V Hormone Disorder Drug Product and Services
Table 147. Ferring B.V Hormone Disorder Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Hormone Disorder Drug Upstream (Raw Materials)
Table 149. Hormone Disorder Drug Typical Customers
Table 150. Hormone Disorder Drug Typical Distributors
LIST OF FIGURES
Figure 1. Hormone Disorder Drug Picture
Figure 2. World Hormone Disorder Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hormone Disorder Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 5. World Hormone Disorder Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hormone Disorder Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Hormone Disorder Drug Production Market Share by Region (2018-2029)
Figure 8. North America Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 9. Europe Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 10. China Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 11. Japan Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 12. Hormone Disorder Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 15. World Hormone Disorder Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 17. China Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 22. India Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hormone Disorder Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hormone Disorder Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hormone Disorder Drug Markets in 2022
Figure 26. United States VS China: Hormone Disorder Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hormone Disorder Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hormone Disorder Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 30. China Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 32. World Hormone Disorder Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hormone Disorder Drug Production Value Market Share by Type in 2022
Figure 34. Growth Hormone Stimulator
Figure 35. Growth Hormone Inhibitor
Figure 36. World Hormone Disorder Drug Production Market Share by Type (2018-2029)
Figure 37. World Hormone Disorder Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Hormone Disorder Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Hormone Disorder Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Hormone Disorder Drug Production Value Market Share by Application in 2022
Figure 41. Dwarfism
Figure 42. Gigantism
Figure 43. Other
Figure 44. World Hormone Disorder Drug Production Market Share by Application (2018-2029)
Figure 45. World Hormone Disorder Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Hormone Disorder Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Hormone Disorder Drug Industry Chain
Figure 48. Hormone Disorder Drug Procurement Model
Figure 49. Hormone Disorder Drug Sales Model
Figure 50. Hormone Disorder Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Hormone Disorder Drug Picture
Figure 2. World Hormone Disorder Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hormone Disorder Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 5. World Hormone Disorder Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hormone Disorder Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Hormone Disorder Drug Production Market Share by Region (2018-2029)
Figure 8. North America Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 9. Europe Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 10. China Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 11. Japan Hormone Disorder Drug Production (2018-2029) & (K Units)
Figure 12. Hormone Disorder Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 15. World Hormone Disorder Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 17. China Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 22. India Hormone Disorder Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hormone Disorder Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hormone Disorder Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hormone Disorder Drug Markets in 2022
Figure 26. United States VS China: Hormone Disorder Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hormone Disorder Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hormone Disorder Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 30. China Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hormone Disorder Drug Production Market Share 2022
Figure 32. World Hormone Disorder Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hormone Disorder Drug Production Value Market Share by Type in 2022
Figure 34. Growth Hormone Stimulator
Figure 35. Growth Hormone Inhibitor
Figure 36. World Hormone Disorder Drug Production Market Share by Type (2018-2029)
Figure 37. World Hormone Disorder Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Hormone Disorder Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Hormone Disorder Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Hormone Disorder Drug Production Value Market Share by Application in 2022
Figure 41. Dwarfism
Figure 42. Gigantism
Figure 43. Other
Figure 44. World Hormone Disorder Drug Production Market Share by Application (2018-2029)
Figure 45. World Hormone Disorder Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Hormone Disorder Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Hormone Disorder Drug Industry Chain
Figure 48. Hormone Disorder Drug Procurement Model
Figure 49. Hormone Disorder Drug Sales Model
Figure 50. Hormone Disorder Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
